Financial Impact of Treatment Choice in Chronic Myeloid Leukemia

That is the title of a recent paper out in ClinicoEconomics and Outcomes Research with co-authors Jennifer Vaughn, Nadine Zawadzki, Shurui Zhang, Paul Pinkston, and David Wei. The subtitle is A Comparison of Later Generation TKIs versus Imatinib from Patient and Payer Perspectives. The abstract is below: Purpose: To evaluate the financial impact of treating CML…

Read More

Why the Future of IDR Depends on Smarter Technology

Focusing on fringe cases of abuse misses a more immediate and arguably more pervasive problem: many provider organizations are not getting the access to IDR they’re entitled to because the process is too difficult to navigate effectively at scale.  The post Why the Future of IDR Depends on Smarter Technology appeared first on MedCity News.

Read More

What Health Systems Miss When Building National Service Lines

Clinical integration is not achieved through governance structures alone. It depends on whether the organization has developed the operational capabilities required to execute consistently across markets that historically functioned independently. The post What Health Systems Miss When Building National Service Lines appeared first on MedCity News.

Read More

In Preliminary Rate Filings, ACA Marketplace Insurers Largely Propose Double-Digit Premium Increase For 2027, Following a Steep Climb This Year 

ACA Marketplace insurers are proposing a median premium increase of 14% for 2027— indicating a likely second consecutive year of double-digit increases, according to a new analysis of preliminary rate filings in 16 states and DC. If these increases hold, typical premiums for insurers participating in the ACA Marketplaces would jump by more than one-third…

Read More